StandardX Launches With £10M Seed Round to Create the Rare Isotopes Needed to Advance Medical and Fusion Innovation
StandardX, the UK-headquartered European deep tech company founded in 2025, has raised £10m seed funding to build the world's first scalable isotope refinery to radically increase production of the rare isotopes that will enable the next century of innovation in medicine and energy. The round was led by Vsquared Ventures and East X Ventures, with additional backing from firstminute capital, UKI2S (the UK Innovation and Science Seed Fund), Brevan Howard Macro Venture and Geometry.
